Sign in
4/A

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001144204-10-067071

Exec VP, Corporate Development bought 15,000 shares at an average $1.90 ($28,458)

From the SEC's structured data for this filing

Trades in this filing

MUSCI RAYMOND · Exec VP, Corporate Development

Table I: Non-derivative

14 lines
Date Transaction Shares Price Value Owned after D/I
2010-12-10 Purchase : show line 1 in the form +200 $1.59 $318 109,155 D
2010-12-10 Purchase : show line 2 in the form +300 $1.60 $480 109,455 D
2010-12-10 Purchase : show line 3 in the form +600 $1.63 $978 110,055 D
2010-12-10 Purchase : show line 4 in the form +100 $1.64 $164 110,155 D
2010-12-10 Purchase : show line 5 in the form +100 $1.70 $170 110,255 D
2010-12-10 Purchase : show line 6 in the form +3,499 $1.79 $6,263 113,754 D
2010-12-10 Purchase : show line 7 in the form +5,000 $1.90 $9,500 118,754 D
2010-12-13 Purchase : show line 8 in the form +266 $1.97 $524 119,020 D
Open-market purchases · 15,000 sh · avg $1.90 · $28,458
Loading xslF345X03/v205930_ex.xml…